FiscalNote adds UK subsidiaries Dragonfly Eye and Oxford Analytica as guarantors under credit agreement

FiscalNote Holdings, Inc.

UK units Dragonfly Eye Ltd and Oxford Analytica Ltd joined as Guarantors under Amended Credit Agreement as of May 16, 2023.
New guarantors granted liens over substantially all their assets to secure their guaranties.
Joinder and Amendment No. 2 also amends and restates the existing credit agreement; no new borrowings disclosed.
All borrowers reaffirmed obligations; no default or event of default occurred.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

FiscalNote Holdings, Inc. amended Joinder and Amendment No. 2 to Second Amended and Restated Credit and Guaranty Agreement with Runway, as administrative agent and collateral agent, and each lender party thereto valued at joins Dragonfly Eye Limited and Oxford Analytica Limited as Guarantors and grants liens over substan (effective 2023-05-16).

Action: amendment
Agreement: credit facility
Counterparty: Runway, as administrative agent and collateral agent, and each lender party thereto
Value: joins Dragonfly Eye Limited and Oxford Analytica Limited as Guarantors and grants liens over substan
Effective: 2023-05-16

Exact text from the filing

On May 16, 2023, FiscalNote, Inc., a wholly owned subsidiary of FiscalNote Holdings, Inc. (the “Company”), entered into that certain Joinder and Amendment No. 2 to Second Amended and Restated Credit and Guaranty Agreement ( “Joinder and Second Amendment”) to its Second Amended and Restated Credit and Guaranty Agreement, dated July 29, 2022

View on SEC.gov

38 material agreements filed in the last 30 days. Browse all material agreements →

FiscalNote Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-022759

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.